Conclusion
The consumption of antibiotics in Slovenia is moderate. At the national level, antibiotic consumption has decreased over the past 2 years both in outpatient and inpatient settings. The resistance rates in some common community pathogens are moderate but show a tendency to increase. The problem of methicillin resistant S. aureus is stable and decreasing. The restrictive measures imposed by the health insurance company, along with the educational efforts of ID specialists have had a major role in reducing the consumption in outpatient settings. In hospitals, effective collaboration of ID specialists with microbiologists, hospital pharmacists, and departmental staff is often impossible due to inadequate awareness of the problem on the part of the management team.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
- Health Insurance Company
- Infectious Disease Specialist
- Antibiotic Consumption
- Infectious Disease Physician
- Antibiotic Policy
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Beović, B., Matos, B., Bošnjak, R., Seme, K., Mueller-Premru, M., Hergouth-Križan, V. et al., 2003, Prevention of nosocomial lower respiratory tract infections in patients after intracranial artery aneurysm surgery with a short course of antimicrobials. Int. J. Antimicrob. Agents, 21.
Černelč, V., 2002, Utilization review of systemic antimicrobials in Slovene hospitals. Med. Razgl., 41(Suppl.), 43–42.
Čižman, M. and Beovič, B., 2002, Priročnik za ambulantno predpisovanje protimikrobnih zdravil. Arkadia.
Čižman, M. and Marolt, M., 1998, Priporočila za uporabo protimikrobnih zdravil KC 1998. Komisija za antibiotike v KC, Klinični center, Sekcija za kemoterapijo SZD.
Čižman, M., Oražem, A., Križan-Hergouth, V., and Kolman, J., 2001a, Correlation between increased consumption of fluoroquinolones in outpatients and resistance of Escherichia coli from urinary tract infections. J. Antimicrob. Chemother., 47, 502.
Čižman, M., Pečar-Čad, S., Stefancic, M., Elseviers, M., Ferech, M., Van der Stichele, R. et al. 2003, Consumption of antibiotics in Slovenia, first results of the ESAC retrospective data collection. ESCMID Meeting, Glasgow.
Čižman, M., Pokorn, M., Paragi, M., and the Slovenian Meningitis Study Group, 2002, Antimicrobial resistance of invasive Streptococcus pneumoniae in Slovenia from 1997 to 2000. J. Antimicrob. Chemother., 49, 582–584.
Čižman, M., Pokorn, M., Seme, K., and Oražem, A., 2001b, The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens. J. Antimicrob. Chemother., 47, 475–477.
Čižman, M., Pokorn, M., Seme, K., Paragi, M., and Oražem, A., 1999, Influence of increased macrolide consumption on macrolide resistance of common respiratory pathogens. Eur. J. Clin. Microbiol. Infect. Dis., 18, 522–524.
Danmap, Danmap 2000-Consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. ISSN 1600-2032.
ESAC—European Surveillance of Antimicrobial Consumption, 2002, Interim report, November 2001–2, 51–76.
Fürst, J., 2001, Primerjava uporabe zdravil v otroški dobi v Sloveniji in Skandinaviji. In C. Kržišnik and T. Battelino (eds.), Izbrana poglavja iz pediatrije. Medicinska fakulteta Univerze v Ljubljani, Katedra za pediatrijo, pp. 71–76.
Gould, I. M., 1999, Stewardship of antibiotic use and resistance surveillance: the international scene. J. Hosp. Infect., 43(Suppl.), 253–260.
Gould, I. M., 2002, Antibiotic policies and control of resistance. Curr. Opin. Infect. Dis., 15, 395–400.
Institute of Public Health of the Republic of Slovenia. Health Statistical Year Book, 2002, Hospital treatment of diseases.
Janknegt, R., Lashof, A. O., Gould, I. M., and van der Meer, J. W. M., 2000, Antibiotic use in Dutch hospitals 1991–1996. J. Antimicrob. Chemother., 45, 251–256.
Keuleyan, E. and Gould, I. M., 2001, Key issues in developing antibiotic policies: From an institutional level to Europe-wide, European Study Group on Antibiotic Policy (ESGAP), Subgroup III. Clin. Microbiol. Infect., 7, 16–21.
Krcmery, V., Jeljaszewicz, J., Grzesiowski, P., Hryniewicz, W, Metodiev, K., Stratchounski, L. et al., 2000, National and local antibiotic policies in central and eastern Europe. J. Chemother., 12, 471–474.
Marolt-Gomišček, M. and Čižman, M., 1992, The usage of antibiotics for outpatients and recommendations for the treatment of bacterial infections. Zdrav. Vestn., 61, 403–406.
Mueller-Premru, M., Seme, K., Kripan-Hergouth, V., Andlovic, A., Kolman, J., and Gubina, M., 2002, Trends of bacterial resistance at the University Medical Center in Ljubljana. Med. Razgl., 41(Suppl. 2), 25–34.
Oražem, A. and Milovanovič, M., 1996, Out-patient prescribing of antibacterials for systemic use in Slovenia. Med. Razgl., 35(Suppl. 1), 1–11.
Sørenson, L. T., and Monnet, D., 2002, Control of antibiotic use in the community: The Danish experience. Infect. Control Hosp. Epidemiol., 21, 387–389.
Standing Medical Advisory Committee, 1998, Subgroup on Antimicrobial Resistance, the path of least resistance. Department of Health http://www.doh.gov.uk/smac.thm
Struelens, M. J., Byl, B., and Vincent, J. L., 1999, Antibiotic policy: A tool for controlling resistance of hospital pathogens. Clin. Microbiol. Infect., 5(Suppl.), 19–24.
Šibane, B., Lešničar, G., and Tratar, F., 2002, Results of controlled antimicrobial treatment at the Celje general hospital between 1995–2000. Med. Razgl., 41(Suppl.), 53–60.
The Swedish Strategic Programme for the rational use of antimicrobial agents (Strama), 2001, O. Cars, K. Ekdahl (eds.) Swedres 2001, A report on Swedish antibiotic utilisation and resistance in human medicine. The Swedish Strategic Programme for the Rational Use of Antimicrobial Agents (STRAMA) and the Swedish Institute for Infectious Disease Control, 23–26.
Van der Meer, J. W. M. and Gyssens, I. C., 2001, Quality of antimicrobial drug prescription in hospital. Clin. Microbiol. Infect., 7(Suppl. 6), 12–15.
Vižintin, T. and Čižman, M., 1998, Antimicrobial usage and trends in the University Medical Centre in Ljubljana from 1995 to 1997. Zdrav. Vestn., 67, 721–725.
White, A. C. Jr., Atmar, R. L., Wilson, J., Cate, T. R., Stager, C. E., and Greenberg, S. B., 1997, Effects of requiring prior authorization for selected antimicrobials: Expenditures, susceptibilities, and clinical outcomes. Clin. Infect. Dis., 25, 230–239.
WHO Collaborating Centre for Drug Statistics Methodology, 2001, Guidelines for ATC classification and DDD assignment. Oslo.
Wilton, P., Smith, R., Coast, J., and Millar, M., 2002, Strategies to contain the emergence of antimicrobial resistance: A systematic review of effectiveness and cost-effectiveness. J. Health Serv. Res. Policy, 7, 111–117.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science + Business Media, Inc.
About this chapter
Cite this chapter
Čižman, M., Beović, B. (2005). Antibiotic Policy—Slovenian Experiences. In: Gould, I.M., van der Meer, J.W.M. (eds) Antibiotic Policies. Springer, Boston, MA. https://doi.org/10.1007/0-387-22852-7_14
Download citation
DOI: https://doi.org/10.1007/0-387-22852-7_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-48500-8
Online ISBN: 978-0-387-22852-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)